Dr. Maldonado attended the Central University of Venezuela (UCV), Biology major. Upon graduation from Biology in 1989, she developed research in chemotherapy of Schistosoma mansoni and Trypanosoma cruzi at the UCV, in several projects supported by the Venezuelan Council of Development Scientific and humanistic (CDCH) and World Health Organization (WHO).<br>In 1992 she entered the PhD program of the Biophysics Institute Carlos Chagas Filho at the Federal University of Rio de Janeiro, Brazil. During her PhD, she developed part of her experimental work at the Northwestern University Medical School, Chicago, ILL. After receiving her Ph.D. degree in 1996, Dr Maldonado obtained a Welcome Trust International Fellowship from UK. From 1999 to 2002, Dr. Maldonado continued her work at the University of São Paulo (USP), and then in Jan 2004 she joined the Federal University of Sao Paulo (UNIFESP) as a visiting professor at the Gene Therapy Center.<br>In October 2004, Dr. Maldonado joined the Dept. of Biological Sciences, University of Texas at El Paso (UTEP), as assistant professor (tenure track).<br>In September 2010 Dr. Maldonado was awarded a Tenure position and was promoted to Associate Professor.<br>In September 1, 2021 Dr. Maldonado was promoted to Professor.

• Outstanding Performance Award for Securing Extramural Funding, Office of Research and Projects (ORSP), College of Science (COS), UTEP - ORSP (01/01/2021-12/31/2021)
• Outstanding Performance Award for Securing Extramural Funding, Office of Research and Projects (ORSP), College of Science (COS), UTEP - ORSP (09/24/2019)
• Patent - USPTO 9,566,320. Title: Mucin-Associated Surface Protein as a Novel Vaccine Candidate Against Chagas Disease. Patent No.: US 9,566,320. Issue: May 7, 2019. Inventors: Maldonado, Rosa A., Serna, Carylinda, and Almeida, Igor C. Status: US Patent issued. Link: https://patentimages.storage.googleapis.com/f6/b8/09/c657e311030501/US9566320.pdf (05/07/2019)
• Outstanding Performance Award for Securing Extramural Funding, Office of Research and Projects (ORSP), College of Science (COS), UTEP - ORSP (08/31/2015)
• 2014 Student Organization Advisor of the Year - American Society of Microbiology - UTEP - Student Organizations Services (05/01/2014-05/31/2014)
• Best undergraduate oral Presentation - American Sociaty for Microbiology Rio Grande Annual Meeting (02/25/2014)
• Best Undergraduate Poster Presentation - Annual Biomedical Reseach Conference for Minority Students /American Sociaty for Microbiology (11/16/2013)
• Oustanding Graduate Student in Pathobiology - UTEP - College of Science (04/21/2013)
• Director of the Bridges to Bacalaureate - NIH (07/01/2011)
• Faculty Marshall of Students - UTEP (05/15/2010)
• Carl Storm Underrepresented Minority Fellowship - Gordon Conference (06/01/2008-06/30/2008)
• Honorary Member of the Golden Key International Honour Society - Golden Key International Honour Society UTEP chapter (01/01/2007-12/31/2007)
• Post-Doctorate schoolaship - São Paulo State Research Support Foundation (FAPESP), São Paulo, Brazil. (06/01/1999)
• Wellcome Trust International Fellow - Wellcome Trust International, United kingdom (05/01/1997)
• Ph.D. Fellowship - Venezuelan Council for Scientific and Technological Research Research (CONICIT), Venezuela. (01/25/1992)
• Undergraduate Scholarship, College of Sciences - Central University of Venezuela (03/01/1982-03/31/1982)

• Molecular Parasitology, University of Dundee (1999)
• Ph D in Molecular Biology, Universidade Federal do Rio de Janeiro, Institute of Biophysics Carlos Chagas Filho (1996)
• BS in Biology, Universidad Central de Venezuela, Facultad de Ciencias (1989)

• Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins. Emerging microbes & infections 11 1 (2022), S M. Viana, Alberto Montoya, A M. Carvalho, B S. de Mendonça, S Portillo, J J. Olivas, N H. Karimi, I L. Estevao, U Ortega-Rodriguez, E M. Carvalho, W O. Dutra, R A. Maldonaldo, Katja Michael, C I. de Oliveira, Igor C. Almeida.
• New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia. BMJ open 11 12 (2021), Cristina Alonso-Vega, Julio A. Urbina, Sergi Sanz, María-Jesús Pinazo, Jimy J. Pinto, Virginia R. Gonzalez, Gimena Rojas, Lourdes Ortiz, Wilsoon Garcia, Daniel Lozano, Dolors Soy, Rosa A. Maldonado-Medina, Rana Nagarkatti, Alain Debrabant, Alejandro Schijman, Maria C. Thomas, Manuel C. López, Katja Michael, Isabela Ribeiro, Joaquim Gascon, Faustino Torrico, Igor C. Almeida.
• Trypanosoma cruzi infection in a bat-eared fox (Otocyon megalotis) with severe focally extensive suppurative myocarditis. Journal of Exotic Pet Medicine 39 (2021), Marc A. Silpa, Felipe Rodriguez, Drury Reavill, Ethan Biswell, Kenneth Waldrup, Rosa A. Maldonado.
• Surveillance of Trypanosoma cruzi Infection in Triatomine Vectors, Feral Dogs and Cats, and Wild Animals in and around El Paso County, Texas, and New Mexico Plos Tropical Neglected Diseases 15 2 (2021), Felipe Rodriguez, Brenda S. Luna, Olivia Calderon, Claudia Manriquez-Roman, Karsten D. Amezcua winter, Jonathan Cedillo, Rebeca A. Garcia-Vasquez, Itzel A. Tejada, Alvaro Romero, Kenneth Waldrup, Douglas Watts, Camilo Khatchikian, Rosa A. Maldonado.
• Glycoconjugates and methods for their use U.S. Patent (2021), Igor C. Almeida, Katja Michael, Nate Schocker, Susana Portillo, Rosa A. Maldonado.
• In Vitro and In Vivo Characterization of Potent Antileishmanial Methionine Aminopeptidase-1 Inhibitors Antimicrobial Agents and Chemotherapy (2020), Felipe Rodriguez, Sarah F. John, Elizabeth Calzada, Eva Iniguez, Sebastian Montalvo, Cristina Gutierrez-Vargas, Karina Michael, Lyndsey White, Dong Liang, Omonike A. Olaleye, Rosa A. Maldonado-Medina.
• A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease. NPJ vaccines 4 (2019), S Portillo, B G. Zepeda, E Iniguez, J J. Olivas, N H. Karimi, O C. Moreira, A F. Marques, Katja Michael, Rosa A. Maldonado-Medina, Igor C. Almeida.
• T. cruzi infection - Methods in Molecular Biology Springer (in press), Uriel Ortega, Susana Portillo, Roger A. Ashmus , Jerry Duram, Nathaniel S. Schocker, Eva Iniguez, Alba L. Montoya, , Brenda G. Zepeda, Janet J. Olivas, Nasim H. Karim, Julio Alonso-Padilla, Luis Izquierdo, , , Maria-Jesús Pinazo, Belkisyolé Alarcón de Noya, Oscar Noya, Rosa A. Maldonado, Faustino Torrico , Joaquim Gascón, Igor C. Almeida.
• A prophylactic alpha-Gal-based glycovaccine effectively protects against murine acute Chagas disease NPJ VACCINES 4 (2019), Susana Portillo, Brenda G. Zepeda, Eva Iniguez, Janet J. Olivas, Nasim H. Karimi, Otacilio C. Moreira, Alexandre F. Marques, Katja Michael, Rosa A. Maldonado-Medina, Igor C. Almeida.
• Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease. Methods in molecular biology (Clifton, N.J.) 1955 (2019), U Ortega-Rodriguez, S Portillo, R A. Ashmus, J A. Duran, N S. Schocker, E Iniguez, A L. Montoya, B G. Zepeda, J J. Olivas, N H. Karimi, J Alonso-Padilla, L Izquierdo, M J. Pinazo, B A. de Noya, O Noya, Rosa A. Maldonado-Medina, F Torrico, J Gascon, Katja Michael, I C. Almeida.
• Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease. Methods in molecular biology (Clifton, N.J.) 1955 (2019), U Ortega-Rodriguez, S Portillo, R A. Ashmus, J A. Duran, N S. Schocker, E Iniguez, A L. Montoya, B G. Zepeda, J J. Olivas, N H. Karimi, J Alonso-Padilla, L Izquierdo, M J. Pinazo, B A. de Noya, O Noya, Rosa A. Maldonado-Medina, F Torrico, J Gascon, Katja Michael, I C. Almeida.
• Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by <i>Leishmania major</i>. Molecules 23 7 (2018), F Rodriguez, E Iniguez, G Pena Contreras, H Ahmed, Costa TEMM, Rachid Skouta, Rosa A. Maldonado-Medina.

• Serological and molecular assessment of potential Trypanosoma cruzi infections in hospitalized parturient women in the U.S-Mexico border (2022), Volume Salta, Rosa A. Maldonado-Medina.
• Serological and molecular assessment of potential Trypanosoma cruzi infections in hospitalized parturient women in the U.S-Mexico border (2022), Volume Mendoza, Rosa A. Maldonado-Medina.
• Glycan-Based Leishmaniasis Diagnostics (2019), Volume Belo Horizonte, Brazil, Rosa A. Maldonado-Medina.
• Novel Nonreducing Linear alpha-Gal Glycotope as Prophylactic Vaccine for Cutaneous Leishmaniasis (2018), Volume San Sebastian, Spain, Rosa A. Maldonado-Medina.
• Novel Experimental Cutaneous Leishmaniasis Vaccine (2018), Volume Houston, Rosa A. Maldonado-Medina.
• Therapeutic Organotin Compounds against Leishmania major (2018), Volume Midland, TX., Keith H. Pannell, itzel A. Tejeda, Rosa A. Maldonado-Medina.
• Protective Carbohydrate-base Vaccine for Cutaneous Leishmaniasis (2018), Volume El Paso, Rosa A. Maldonado-Medina.

• Bridges to the Baccalaureate Program